Dr. Lawrence is a clinician researcher fully engaged in the “One Health” directive as she strives to improve our understanding of the pathobiology, diagnosis, treatment and prevention of human and animal cancer and treatment-related toxicities. In particular, she is keen to improve radiation killing of cancer cells while limiting radiation-induced injury to normal tissue that may result in treatment-related complications such as organ fibrosis and bystander injury. As cancer survivors (pet or human) enjoy improved outcomes after radiation therapy for many tumor types, it is important that cancer researchers investigate treatment methods to maintain or improve quality of life after treatment. By furthering our understanding of the signals that occur after radiation in normal and cancer cells, Dr. Lawrence and her collaborators hope to develop strategies that mitigate radiation-induced injury to normal tissue.
